Clinical observations and research studies provide insight into typical response patterns, though individual results vary significantly based on factors including baseline skin tone, dosage, frequency of administration, and overall health status
After three decades and more than two hundred papers, there is still no published randomized controlled trial showing efficacy
Microdosing refers to using lower-than-standard doses of these medications, often below the doses commonly prescribed for weight loss
We highlight several often-neglected additional therapeutic advantages of GLP-1 RAs, such as their ability to decrease neuroinflammation and immune senescence, along with the potential for GLP-1 RAs to help lower vascular stiffness and combat sarcopenia, both of which are major factors affecting mobility, resilience, and overall health in older individuals
This opens up the possibility of our gene therapy targeting the GSH system
Some SSRIsparticularly paroxetinehave been associated with weight gain over long-term use
